The data showed that CB is a potent anti-tumor agent, and it further increased FOXO1-induced DDP chemosensitivity by antagonizing MYH9, which regulates GSK3β/β-catenin-mediated tumor stemness and EMT signals in NPC. Here, MYH9 is linked to neoplasm.